Skip to main content

ORIGINAL RESEARCH article

Front. Physiol., 22 December 2015
Sec. Gastrointestinal Sciences
This article is part of the Research Topic Inositide signaling targets in gastrointestinal diseases View all 7 articles

Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK

Retracted
\r\nNiamat Khan,Niamat Khan1,2D. V. Krishna PantakaniD. V. Krishna Pantakani1Lutz BinderLutz Binder1Muhammad Qasim,Muhammad Qasim1,3Abdul R. Asif*Abdul R. Asif1*
  • 1Proteomics Group, Institute for Clinical Chemistry/UMG-Laboratories, University Medical Centre, Goettingen, Germany
  • 2Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat, Pakistan
  • 3Department of Microbiology, Kohat University of Science and Technology, Kohat, Pakistan

Citation: Khan N, Pantakani DVK, Binder L, Qasim M and Asif AR (2015) Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Front. Physiol. 6:381. doi: 10.3389/fphys.2015.00381

Received: 20 September 2015; Accepted: 24 November 2015;
Published: 22 December 2015; Retracted: 19 September 2017.

Edited by:

Alexis E. Traynor-Kaplan, ISM Therapeutics, USA

Reviewed by:

Georg Singer, Medical University of Graz, Austria
R. John MacLeod, Queen's University, Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.